iofetamine has been researched along with Lewy Body Disease in 11 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination." | 5.37 | Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011) |
| "A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination." | 1.37 | Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, F | 1 |
| Shiraishi, S | 1 |
| Yoshida, M | 1 |
| Tomiguchi, S | 1 |
| Hirai, T | 1 |
| Namimoto, T | 1 |
| Hashimoto, M | 1 |
| Ikeda, M | 1 |
| Uetani, H | 1 |
| Yamashita, Y | 1 |
| Tanaka, K | 1 |
| Wada, I | 1 |
| Okunomiya, T | 1 |
| Shima, A | 1 |
| Kambe, D | 1 |
| Shinde, A | 1 |
| Kageyama, T | 1 |
| Suenaga, T | 1 |
| Chiba, Y | 1 |
| Iseki, E | 1 |
| Fujishiro, H | 1 |
| Ota, K | 1 |
| Kasanuki, K | 1 |
| Suzuki, M | 1 |
| Hirayasu, Y | 1 |
| Arai, H | 1 |
| Sato, K | 1 |
| Maeda, K | 1 |
| Ogawa, N | 1 |
| Yamamoto, Y | 1 |
| Onoguchi, M | 1 |
| Wada, A | 1 |
| Sarada, K | 1 |
| Haramoto, M | 1 |
| Komatsu, A | 1 |
| Kitagaki, H | 1 |
| Yamaguchi, S | 1 |
| Kamei, H | 1 |
| Nakajima, T | 1 |
| Fukuhara, N | 1 |
| Ishii, K | 1 |
| Hosaka, K | 1 |
| Mori, T | 1 |
| Mori, E | 1 |
| Kasama, S | 1 |
| Tachibana, H | 1 |
| Kawabata, K | 1 |
| Yoshikawa, H | 1 |
| Mito, Y | 1 |
| Yoshida, K | 1 |
| Yabe, I | 1 |
| Makino, K | 1 |
| Hirotani, M | 1 |
| Tashiro, K | 1 |
| Kikuchi, S | 1 |
| Sasaki, H | 1 |
| Hanyu, H | 1 |
| Shimizu, S | 1 |
| Hirao, K | 1 |
| Kanetaka, H | 1 |
| Iwamoto, T | 1 |
| Chikamori, T | 1 |
| Usui, Y | 1 |
| Yamashina, A | 1 |
| Koizumi, K | 1 |
| Abe, K | 1 |
| Inui, Y | 1 |
| Toyama, H | 1 |
| Manabe, Y | 1 |
| Sato, T | 1 |
| Sarai, M | 1 |
| Kosaka, K | 1 |
| Iwata, N | 1 |
| Katada, K | 1 |
1 trial available for iofetamine and Lewy Body Disease
| Article | Year |
|---|---|
Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging.
Topics: Aged; Alzheimer Disease; Brain Diseases; Cerebrovascular Circulation; Cognition Disorders; Humans; I | 2005 |
10 other studies available for iofetamine and Lewy Body Disease
| Article | Year |
|---|---|
Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Area Under Curve; Brain; Female; Humans; Iofetamine; | 2014 |
Dropped head syndrome preceding the onset of dementia with Lewy bodies.
Topics: Aged; Brain; Cholinergic Antagonists; Female; Humans; Iofetamine; Lewy Body Disease; Magnetic Resona | 2014 |
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fl | 2016 |
Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB.
Topics: Aged; Amitriptyline; Catatonia; Cerebrovascular Circulation; Female; Humans; Iofetamine; Lewy Body D | 2011 |
[Evaluation of shortened protocol of graph plot method with ¹²³I-IMP].
Topics: Aged; Brain; Cerebral Infarction; Cerebrovascular Circulation; Female; Humans; Iofetamine; Lewy Body | 2011 |
[Statistic rCBF study of extrapyramidal disorders].
Topics: Aged; Basal Ganglia Diseases; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; | 2002 |
Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Iofetamine; Lewy Body Disease; Male; Positron-E | 2004 |
Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cerebrovascular Circulation; Femal | 2005 |
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine; | 2006 |
Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Heart; Humans; Imaging, Three-Dimensi | 2007 |